Serotonergic activation reduces defensive freezing in the conditioned fear paradigm

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 825-831

  Inoue, Takeshi ^a   Tsuchiya, Kiyoshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

5 HT(1A) receptor; Anxiety; Anxiolytic; Citalopram; Conditioned fear stress; Freezing behavior; Ipsapirone; Serotonin

Indexed keywords

2 [[2 (DIMETHYLAMINO)ETHYL]THIO] 3 PHENYLQUINOLINE; 5 HYDROXYTRYPTOPHAN; BENSERAZIDE; CHLORAMPHETAMINE; CITALOPRAM; DIAZEPAM; FENCLONINE; IPSAPIRONE; KETANSERIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN INJURY; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; ELECTRIC SHOCK; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC TRANSMISSION; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029885647     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02084-5     Document Type: Article

References (39)

1. Black, D. W.; Wesner, R.; Bowers, W.; Gabel, J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch. Gen. Psychiatry 50:44-50; 1993.
2. Blanchard, D. C.; Blanchard, R. J. Crouching as an index of fear. J. Comp. Physiol. Psychol. 67:370-375; 1969.
3. Bouton, M. E.; Bolles, R. C. Conditioned fear assessed by freezing and by the suppression of three different baselines. Anim. Learn. Behav. 8:429-434; 1980.
4. Brown, C. S.; Rakel, R. E.; Wells, B. G.; Downs, J. M.; Akiskal, H. S. A practical update on anxiety disorders and their pharmacological treatment. Arch. Intern. Med. 151:873-884; 1991.
5. Carli, M.; Prontera, C.; Samanin, R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br. J. Pharmacol. 96:829-836; 1989.
6. 1A receptors in the anticonflict effect of ipsapirone in rats. Neuropharmacology 30:703-709; 1991.
7. Chopin, P.; Briley, M. Animal models of anxiety: The effects of compounds that modify 5-HT neurotransmission. Trends Pharmacol. Sci. 8:383-387; 1987.
8. Den Boer, J. A.; Westenberg, H. G. M. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: A double-blind comparative study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol. 3:59-74; 1988.
9. Deutch, A. Y.; Tam, S.-Y.; Roth, R. H. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res. 333:143-146; 1985.
10. 1A receptors in depression and anxiety. New York: Raven Press; 1992:55-81.
11. 1A autoreceptors in the raphe nuclei. Trends Pharmacol. Sci. 7:212-214; 1986.
12. Eison, A. S.; Eison, M. S.; Stanley, M.; Riblet, L. A. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol. Biochem. Behav. 24:701-707; 1986.
13. Erikkson, E.; Humble, M. Serotonin in psychiatric pathophysiology: A review of data from experimental and clinical research. In: Pohl, R.; Gershon, S., eds. Progress in basic clinical pharmacology, vol. 3: The biological basis of psychiatric treatment. Basel: Karger; 1990:66-119.
14. Ervin, G. N.; Carter, R. B.; Webster, E. L.; Moore, S. I.; Cooper, B. R. Evidence that taste aversion learning induced by L-5-hydroxytryptophan is mediated peripherally. Pharmacol. Biochem. Behav. 20:799-802; 1984.
15. Fanselow, M. S. Conditional and unconditional components of postshock freezing. Pavlov. J. Biol. Sci. 15:177-182; 1980.
16. Fanselow, M. S.; Helmstetter, F. J. Conditional analgesia, defensive freezing, and benzodiazepines. Behav. Neurosci. 102:233-243; 1988.
17. Fuller, R. W. Effects of p-chloroamphetamine on brain serotonin neurons. Neurochem. Res. 5:449-456; 1992.
18. 1A receptors in depression and anxiety. New York: Raven Press; 1992:35-53.
19. 1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal. Psychopharmacology 103:529-537; 1991.
20. Handley, S. L.; McBlane, J. W. 5-HT drugs in animal models of anxiety. Psychopharmacology 112:13-20; 1993.
21. Herman, J. P.; Guillonneau, D.; Dantzer, R.; Scatton, B.; Semerdjian-Rouquier, L.; Le Moal, M. Differential effects of inescapable foot shocks and of stimuli previously paired with inescapable foot shocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30:2207-2214; 1982.
22. 1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology 106:261-267; 1992.
23. 1A receptors in depression and anxiety. New York: Raven Press; 1992:109-117.
24. Hyttel, J. Citalopram. Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6:277-295; 1982.
25. 1A agonist reduced conditioned freezing behavior. Soc. Neurosci. Abstr. 18: 1530; 1992.
26. Inoue, T.; Koyama, T.; Yamashita, I. Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol. Biochem. Behav. 44:371-374; 1993.
27. Inoue, T.; Tsuchiya, K.; Koyama, T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol. Biochem. Behav. 49:911-920; 1994.
28. Kahn, R. S.; Westenberg, H. G. M.; Verhoeven, W. M. A.; Gispen-de Wied, C. C.; Kamerbeek, W. D. J. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int. Clin. Psychopharmacol. 2:33-45; 1987.
29. Kahn, R. S.; van Praag, H. M.; Wetzler, S.; Asnis, G. M.; Barr, G. Serotonin and anxiety revisited. Biol. Psychiatry 23:189-208; 1988.
30. Kostowski, W.; Plaznik, A.; Stefanski, R. Intra-hippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol. 168: 393-396; 1989.
31. Middlemiss, D. N.; Tricklebank, M. D. Centrally active 5-HT receptor agonists and antagonists. Neurosci. Biobehav. Rev. 16: 75-82; 1992.
32. Morgan, M. A.; Romanski, L. M.; LeDoux, J. E. Extinction of emotional learning: Contribution of medial prefrontal cortex. Neurosci. Lett. 163:109-113; 1993.
33. Palkovits, M.; Brownstein, M. J. Maps and guide to microdissection of the rat brain. New York: Elsevier; 1988.
34. 1A receptors is responsible for the anticonflict effect of ipsapirone in rats. J. Pharm. Pharmacol. 44:780-782; 1992.
35. 1A agonist, in three stress paradigms: Immobilization, forced swim and conditioned fear. Brain Res. 580:205-214; 1992.
36. 1A receptor agonists. Neuropharmacology 32:977-985; 1993.
37. 1A receptor-related anxiolytics. Trends Pharmacol. Sci. 8:432-437; 1987.
38. Treit, D. Animal models for the study of anti-anxiety agents: A review. Neurosci. Biobehav. Rev. 9:203-222; 1985.
39. Tsuda, A.; Tanaka, M.; Ida, Y.; Tsujimaru, S.; Ushijima, I.; Nagasaki, N. Effects of preshock experience on enhancement of rat brain noradrenaline turnover induced by psychological stress. Pharmacol. Biochem. Behav. 24:115-119; 1986.